EAM Investors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,563
Closed -$1.3M 403
2023
Q2
$1.3M Buy
+4,563
New +$1.27M 0.24% 190
2022
Q4
Sell
-10,116
Closed -$2.81M 359
2022
Q3
$2.81M Buy
+10,116
New +$2.57M 0.61% 39
2022
Q1
Sell
-7,597
Closed -$1.35M 415
2021
Q4
$1.35M Sell
7,597
-7,841
-51% -$1.55M 0.22% 222
2021
Q3
$3.18M Sell
15,438
-1,397
-8% -$274K 0.54% 42
2021
Q2
$3.19M Buy
+16,835
New +$2.76M 0.49% 50
2021
Q1
Sell
-19,397
Closed -$2.01M 462
2020
Q4
$2.01M Sell
19,397
-4,516
-19% -$391K 0.33% 117
2020
Q3
$1.81M Buy
+23,913
New +$1.36M 0.43% 71
2019
Q3
Sell
-18,833
Closed -$1.07M 312
2019
Q2
$1.07M Buy
+18,833
New +$915K 0.26% 178

Other funds holding SWAV

EAM Investors's SWAV Position: Q3 2023 in Review

EAM Investors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2023, closing a stake of 4,563 shares — an estimated $1.3M sold.

EAM Investors first reported a position in SWAV in Q2 2019 and held it in 8 quarters. The position peaked at $3.19M in Q2 2021. 412 funds tracked by Wall St. Rank hold SWAV as of Q3 2023.

  • EAM Investors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • EAM Investors sold 4,563 Shockwave Medical, Inc. Common Stock shares in Q3 2023, an estimated $1.3M.
  • EAM Investors first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2019 and held it in 8 quarters.
  • EAM Investors's Shockwave Medical, Inc. Common Stock position peaked at $3.19M in Q2 2021.
  • 412 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2023.

Based on EAM Investors's 13F filing for Q3 2023, filed 13 Nov 2023.